Literature DB >> 11846807

Synthesis and turn-over of the replicative Cdc6 protein during the HeLa cell cycle.

Esther Biermann1, Martina Baack, Sandra Kreitz, Rolf Knippers.   

Abstract

The human replication protein Cdc6p is translocated from its chromatin sites to the cytoplasm during the replication phase (S phase) of the cell cycle. However, the amounts of Cdc6p on chromatin remain high during S phase implying either that displaced Cdc6p can rebind to chromatin, or that Cdc6p is synthesized de novo. We have performed metabolic labeling experiments and determined that [35S]methionine is incorporated into Cdc6p at similar rates during the G1 phase and the S phase of the cell cycle. Newly synthesized Cdc6p associates with chromatin. Pulse-chase experiments show that chromatin-bound newly synthesized Cdc6p has a half life of 2-4 h. The results indicate that, once bound to chromatin, pulse-labeled new Cdc6p behaves just as old Cdc6p: it dissociates and eventually disappears from the nucleus. The data suggest a surprisingly dynamic behaviour of Cdc6p in the HeLa cell cycle.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11846807     DOI: 10.1046/j.0014-2956.2001.02746.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  4 in total

1.  The functional role of Cdc6 in S-G2/M in mammalian cells.

Authors:  Eric Lau; Changjun Zhu; Robert T Abraham; Wei Jiang
Journal:  EMBO Rep       Date:  2006-01-27       Impact factor: 8.807

2.  p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer.

Authors:  N Murphy; M Ring; C C B B Heffron; B King; A G Killalea; C Hughes; C M Martin; E McGuinness; O Sheils; J J O'Leary
Journal:  J Clin Pathol       Date:  2005-05       Impact factor: 3.411

3.  At the crossroads of SUMO and NF-kappaB.

Authors:  Martin P Kracklauer; Christian Schmidt
Journal:  Mol Cancer       Date:  2003-11-05       Impact factor: 27.401

4.  Significance of DNA Replication Licensing Proteins (MCM2, MCM5 and CDC6), p16 and p63 as Markers of Premalignant Lesions of the Uterine Cervix: Its Usefulness to Predict Malignant Potential

Authors:  V N Saritha; V S Veena; K M Jagathnath Krishna; Thara Somanathan; K Sujathan
Journal:  Asian Pac J Cancer Prev       Date:  2018-01-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.